E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/8/2011 in the Prospect News PIPE Daily.

Aqua Bio Technology arranges NOK 15 million convertible loan agreement

Insiders to invest NOK 400,000 in company via loan due Dec. 31, 2012

By Devika Patel

Knoxville, Tenn., Nov. 8 - Aqua Bio Technology ASA said it will raise between NOK 7 million and NOK 15 million through a convertible loan due Dec. 31, 2012.

The loan may be converted into shares at NOK 6.00 per share.

Chief executive officer Arvid Lindberg will invest NOK 100,000, chairman of the board John Afseth will invest NOK 250,000 and board member Tone Bjørnov will invest NOK 50,000.

The Sandefjord, Norway, company develops and markets patented ingredients and technology to the international cosmetics and skin care industry.

Issuer:Aqua Bio Technology ASA
Issue:Convertible loan
Amount:NOK 7 million (minimum), NOK 15 million (maximum)
Maturity:Dec. 31, 2012
Conversion price:NOK 6.00
Warrants:No
Investors:Arvid Lindberg (for NOK 100,000), John Afseth (for NOK 250,000), Tone Bjørnov (for NOK 50,000)
Pricing date:Nov. 8
Stock symbol:Oslo: ATB

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.